Skip to content

A study on the effectiveness of gargling to prevent oral mucositis caused by chemotherapy or radiochemotherapy

A study on the effectiveness of gargling to prevent oral mucositis caused by chemotherapy or radiochemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1021260004
Enrollment
100
Registered
2026-04-30
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer, breast cancer, and gynecological cancer scheduled for initial chemotherapy or

Interventions

Following the instructions in the package insert, prepare a gargle solution by dissolving 5 drops of Azunol 4% gargle solution in 100 ml of tap water. In both groups, the following interventions will

Sponsors

Saji Shigehira
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients who are 18 years of age or older at the time of consent 2)Patients with head and neck cancer, breast cancer, or gynecological cancer who are scheduled for initial chemotherapy or chemotherapy with radiation

Exclusion criteria

Exclusion criteria: 1)Patients using oral steroid ointment 2)Patients with impaired swallowing function who are at risk of aspiration 3)Other patients who are deemed ineligible by the principal investigator and co-investigators

Design outcomes

Primary

MeasureTime frame
CTCAE Ver.3.0 Oral mucositis incidence rate of Grade 2 or higher

Contacts

Public ContactMomoyo Kojima

Fukushima Medical University Hospital

m-kojima@fmu.ac.jp+81-24-547-1352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026